Ptf1a Promoter-Driven Cre Expression During Spermatogenesis Causes Germline Recombination

被引:0
|
作者
Wang, Jiale [1 ]
Wang, Oliver [1 ]
Bi, Yan [2 ]
Wang, Ying [3 ]
Crawford, Howard [4 ]
Ji, Baoan [1 ]
机构
[1] Mayo Clin, Dept Ctr Biol, Jacksonville, FL 32224 USA
[2] Mayo Clin, Gastroenterol & Hepatol, Jacksonville, FL 32224 USA
[3] Mayo Clin, Dept Cardiovasc Med, Rochester, MN USA
[4] Henry Ford Pancreat Canc Ctr, Detroit, MI USA
关键词
genetic mouse model; pancreatic cancer; pancreatitis;
D O I
10.1097/MPA.0000000000001961
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Objectives: Two independently developed Ptf1a-Cre mouse lines, Ptf1a(tm1(cre)Hnak) and Ptf1a(tm1(Cre)Cvw), are widely used in pancreatic research. Recently, Ptf1a(tm1(cre)Hnak) line was reported to transmit unwanted paternal recombination. We aimed to investigate whether this exists in the Ptf1a(tm1(Cre)Cvw) line. Methods: Ptf1a(tm1(Cre)Cvw) mice were crossed with R26-LSL-LacZ reporter mice. DNA recombination and gene expression were examined by recombination-specific polymerase chain reaction, reverse transcription-polymerase chain reaction, and X-Gal staining. Results: R26 locus recombination was detected in the pancreas as well as the testes and sperm of the double transgenic mice. Positive ptf1a mRNA expression from testes revealed that there was endogenous Ptf1a promoter activity in this extrapancreatic tissue. Of the 15 progenies that inherited LacZ from the male double transgenic mice, 4 (26.7%) were positive for complete whole-body recombination. The presence of recombination in R26 only mice suggested that the recombination occurred before meiosis. Conclusions: Paternal germline recombination exists in the Ptf1a(tm1(Cre)Cvw) mouse line. Ptf1a promoter-driven Cre expression during spermatogenesis before meiosis is the cause of germline recombination. Therefore, when male Ptf1a-Cre mice are used in compound mice breeding, it is necessary to genotype not only floxed alleles but also recombined alleles to examine unwanted recombinations.
引用
收藏
页码:90 / 93
页数:4
相关论文
共 50 条
  • [31] In vivo imaging and therapy of breast cancer xenografts following MUC1 promoter-driven expression of the sodium iodide symporter (NIS)
    Dwyer, RM
    Bergert, ER
    O'Connor, MK
    Gendler, SJ
    Morris, JC
    MOLECULAR THERAPY, 2004, 9 : S12 - S12
  • [33] Erythroid-specific inactivation of Slc12a6/Kcc3 by EpoR promoter-driven Cre expression reduces K-Cl cotransport activity in mouse erythrocytes
    Shmukler, Boris E.
    Rivera, Alicia
    Nishimura, Katherine
    Hsu, Ann
    Wohlgemuth, Jay G.
    Dlott, Jeffrey S.
    Snyder, L. Michael
    Brugnara, Carlo
    Alper, Seth L.
    PHYSIOLOGICAL REPORTS, 2022, 10 (05):
  • [34] Dysregulated expression of P1 and P2 promoter-driven hepatocyte nuclear factor-4α in the pathogenesis of human cancer
    Tanaka, T
    Jiang, S
    Hotta, H
    Takano, K
    Iwanari, H
    Sumi, K
    Daigo, K
    Ohashi, R
    Sugai, M
    Ikegame, C
    Umezu, H
    Hirayama, Y
    Midorikawa, Y
    Hippo, Y
    Watanabe, A
    Uchiyama, Y
    Hasegawa, G
    Reid, PC
    Aburatani, H
    Hamakubo, T
    Sakai, J
    Naito, M
    Kodama, T
    JOURNAL OF PATHOLOGY, 2006, 208 (05): : 662 - 672
  • [35] Bone-directed expression of Col1a1 promoter-driven self-inactivating retroviral vector in bone marrow cells and transgenic mice
    Stover, ML
    Wang, CKL
    McKinstry, MB
    Kalajzic, I
    Gronowicz, G
    Clark, SH
    Rowe, DW
    Lichtler, AC
    MOLECULAR THERAPY, 2001, 3 (04) : 543 - 550
  • [36] Naf1 Regulates HIV-1 Latency by Suppressing Viral Promoter-Driven Gene Expression in Primary CD4+ T Cells
    Li, Chuan
    Wang, Hai-Bo
    Kuang, Wen-Dong
    Ren, Xiao-Xin
    Song, Shu-Ting
    Zhu, Huan-Zhang
    Li, Qiang
    Xu, Li-Ran
    Guo, Hui-Jun
    Wu, Li
    Wang, Jian-Hua
    JOURNAL OF VIROLOGY, 2017, 91 (01)
  • [37] mdr1 promoter-driven tumor necrosis factor-α expression for a chemotherapy-controllable combined in vivo gene therapy and chemotherapy of tumors
    Walther, W
    Stein, U
    Fichtner, I
    Alexander, M
    Shoemaker, RH
    Schlag, PM
    CANCER GENE THERAPY, 2000, 7 (06) : 893 - 900
  • [38] H1 RNA polymerase III promoter-driven expression of an RNA aptamer leads to high-level inhibition of intracellular protein activity
    Mi, Jing
    Zhang, Xiuwu
    Rabbani, Zahid N.
    Liu, Yingmiao
    Su, Zhen
    Vujaskovic, Zeljko
    Kontos, Christopher D.
    Sullenger, Bruce A.
    Clary, Bryan M.
    NUCLEIC ACIDS RESEARCH, 2006, 34 (12) : 3577 - 3584
  • [39] Expression of the IP3R1 Promoter-Driven nls-LacZ Transgene in Purkinje Cell Parasagittal Arrays of Developing Mouse Cerebellum
    Furutama, Daisuke
    Morita, Noriyuki
    Takano, Riya
    Sekine, Yukiko
    Sadakata, Tetsushi
    Shinoda, Yo
    Hayashi, Kanehiro
    Mishima, Yuriko
    Mikoshiba, Katsuhiko
    Hawkes, Richard
    Furuichi, Teiichi
    JOURNAL OF NEUROSCIENCE RESEARCH, 2010, 88 (13) : 2810 - 2825
  • [40] mdr1 promoter-driven tumor necrosis factor-α expression for a chemotherapy-controllable combined in vivo gene therapy and chemotherapy of tumors
    Wolfgang Walther
    Ulrike Stein
    Iduna Fichtner
    Mark Alexander
    Robert H Shoemaker
    Peter M Schlag
    Cancer Gene Therapy, 2000, 7 : 893 - 900